NO976067L - Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon - Google Patents

Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon

Info

Publication number
NO976067L
NO976067L NO976067A NO976067A NO976067L NO 976067 L NO976067 L NO 976067L NO 976067 A NO976067 A NO 976067A NO 976067 A NO976067 A NO 976067A NO 976067 L NO976067 L NO 976067L
Authority
NO
Norway
Prior art keywords
preparation
stage
daily
oestrogen
unit doses
Prior art date
Application number
NO976067A
Other languages
English (en)
Other versions
NO317671B1 (no
NO976067D0 (no
Inventor
Karin Schmidt-Gollwitzer
Walter Klemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO976067D0 publication Critical patent/NO976067D0/no
Publication of NO976067L publication Critical patent/NO976067L/no
Publication of NO317671B1 publication Critical patent/NO317671B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Surgical Instruments (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO19976067A 1995-06-28 1997-12-23 Farmasoytisk kombinasjonspreparat, sett og fremgangsmate for hormonell prevensjon NO317671B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19525017A DE19525017A1 (de) 1995-06-28 1995-06-28 Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
PCT/DE1996/001192 WO1997001342A1 (de) 1995-06-28 1996-06-27 Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption

Publications (3)

Publication Number Publication Date
NO976067D0 NO976067D0 (no) 1997-12-23
NO976067L true NO976067L (no) 1998-02-27
NO317671B1 NO317671B1 (no) 2004-11-29

Family

ID=7766408

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19976067A NO317671B1 (no) 1995-06-28 1997-12-23 Farmasoytisk kombinasjonspreparat, sett og fremgangsmate for hormonell prevensjon

Country Status (22)

Country Link
US (2) US6027749A (no)
EP (1) EP0835114B1 (no)
JP (1) JPH11508538A (no)
CN (1) CN1137690C (no)
AT (1) ATE239483T1 (no)
AU (1) AU6352896A (no)
BR (1) BR9609317A (no)
CA (1) CA2225724C (no)
CZ (1) CZ420597A3 (no)
DE (2) DE19525017A1 (no)
DK (1) DK0835114T3 (no)
ES (1) ES2199293T3 (no)
HU (1) HU223976B1 (no)
IL (1) IL122109A (no)
MX (1) MX9800026A (no)
NO (1) NO317671B1 (no)
NZ (1) NZ312081A (no)
PT (1) PT835114E (no)
RU (1) RU98101254A (no)
SK (1) SK178097A3 (no)
WO (1) WO1997001342A1 (no)
ZA (1) ZA965547B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE69729956T2 (de) * 1996-07-26 2004-12-16 Wyeth Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
JP4354667B2 (ja) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US7297688B2 (en) 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
CN100581550C (zh) 2001-12-05 2010-01-20 杜拉美德药物有限公司 预防怀孕和减少经期前症状的口服避孕药
PT1635843E (pt) * 2003-06-25 2009-04-07 Bayer Schering Pharma Ag Terapia de substituição hormonal e de depressão compreendendo dienogest
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
WO2005032558A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE102004026670A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20060205701A1 (en) * 2005-02-15 2006-09-14 Sabine Fricke Solid peroral contraceptive preparations
ES2310907T3 (es) * 2005-02-15 2009-01-16 JENAPHARM GMBH & CO. KG Forma de medicamento peroral solida para la contracepcion, que contiene dienogest y etinilestradiol.
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
EP1690529A1 (de) * 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
US20070072836A1 (en) * 2005-02-15 2007-03-29 Sabine Fricke Solid peroral contraceptive preparations
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1993531B1 (en) * 2006-03-02 2015-10-14 Warner Chilcott Company, LLC Extended cycle multiphasic oral contraceptive method
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US9198919B2 (en) * 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
ES2734510T3 (es) * 2008-10-08 2019-12-10 Agile Therapeutics Inc Administración transdérmica
CA2740004A1 (en) * 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2410859A4 (en) * 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
RS65196B1 (sr) * 2015-06-23 2024-03-29 Laboratorios Leon Farma Sa Kontraceptivno sredstvo na bazi drospirenona za pacijentkinje sa viškom težine
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US5320850A (en) 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
HU223976B1 (hu) 2005-03-29
MX9800026A (es) 1998-03-31
WO1997001342A1 (de) 1997-01-16
ATE239483T1 (de) 2003-05-15
US6027749A (en) 2000-02-22
NZ312081A (en) 1999-04-29
HUP9900252A2 (hu) 1999-05-28
AU6352896A (en) 1997-01-30
DE59610425D1 (de) 2003-06-12
JPH11508538A (ja) 1999-07-27
BR9609317A (pt) 1999-07-06
EP0835114A1 (de) 1998-04-15
IL122109A0 (en) 1998-04-05
US6312722B1 (en) 2001-11-06
DE19525017A1 (de) 1997-01-02
CA2225724A1 (en) 1997-01-16
PT835114E (pt) 2003-09-30
RU98101254A (ru) 2000-01-27
DK0835114T3 (da) 2003-09-01
EP0835114B1 (de) 2003-05-07
SK178097A3 (en) 1998-05-06
CN1137690C (zh) 2004-02-11
HUP9900252A3 (en) 2001-09-28
CZ420597A3 (cs) 1998-03-18
IL122109A (en) 2006-07-05
NO317671B1 (no) 2004-11-29
CA2225724C (en) 2008-01-15
ES2199293T3 (es) 2004-02-16
CN1189101A (zh) 1998-07-29
NO976067D0 (no) 1997-12-23
ZA965547B (en) 1997-01-27

Similar Documents

Publication Publication Date Title
NO976067D0 (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
AU2073595A (en) Combined hormonal contraception pharmaceutical preparation
AU1191092A (en) Ovulation-preventing agent for hormonal contraception
FI103951B1 (fi) Ehkäisyjärjestelmä
DK351887A (da) Kombinationsdosisform til hormonbehandling og kontraception for kvinder i praemenopausen
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
NO982902D0 (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
NZ333750A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
NO974630D0 (no) Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
DK0921804T3 (da) Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen
Crist Post-coital estrogen